Bayer Schering Pharma
In 2007, Bayer absorbed Schering AG and formed Bayer Schering Pharma. The acquisition of Schering was the biggest takeover in Bayer's history. The name of the company was changed to Bayer Pharma in 2011. Bayer Healthcare Pharmaceuticals consists of two units - General and Special Medicine.
Women's health care is one of the areas covered by the Department of General Medicine. Bayer Pharma produces birth control pills Yaz and Yasmin. Both drugs use a new type of hormone progesterone - drospirenone - in combination with estrogen.
An example of the activities of the department of special medicine is the development of technologies for obtaining diagnostic images. The contrast agents developed by this department help early and accurate definition of the disease and the choice of optimal treatment. Methods for obtaining diagnostic images, such as computed tomography, nuclear magnetic resonance tomography and ultrasound, are used for contrast imaging of organs and tissues in their natural positions within the body. The work of the department is also focused on the development of labeling substances for positron emission tomography (PET). One of these labeling substances, Florbetaben, produced by Bayer, allows one to identify beta amyloid, one of the hallmarks of Alzheimer's disease, with great accuracy in a still living patient.
Always take the Balkan! But this time the bayer ordered, decided to evaluate the German quality, according to the results I will inform you!)